diltiazem

Diltiazem (CRD 401 free base) is an orally available L-type Ca2+ channel blocker with antihypertensive, antiarrhythmic, and cardioprotective properties that prevent post-reperfusion myocardial injury, angina pectoris, and cardiovascular-related diseases.

Diltiazem hydrochloride (RG 83606 HCl) is a benzothiazepine calcium channel blocking agent with vasodilating action due to its antagonism of the actions of CALCIUM ion on membrane functions.

Diltiazem malate is an ACE inhibitor and non-dihydropyridine calcium channel blocker used in the treatment of hypertension.

N-Demethyldiltiazem HCl is a non-dihydropyridine calcium channel blocker.

Deacetyldiltiazem is a metabolite product of Diltiazem which is a coronary vasodilator, and is present in the plasma of individuals taking Diltiazem.

Deacetyl-N-monodemethyldiltiazem is a major metabolites of diltiazem.

O-Demethyldeacetyldiltiazem is one of the diltiazem metabolites in human plasma.

O-Demethyldeacetyldiltiazem hydrochloride is a biochemical.

N-Demethyldiltiazem is a non-dihydropyridine calcium channel blocker.

Deacetyl-N,O-didemethyldiltiazem is a biochemical.

Siratiazem [LRA 113] is a calcium channel antagonist structurally similar to diltiazem, distinguished by having a branched alkyl group on its basic nitrogen atom.

Clentiazem (free base) is a calcium channel blocker. It is a chlorine derivative of diltiazem.

AJG-049 HCl is a calcium channel antagonist that inhibits L-type Ca2+ channels via diltiazem-binding site(s).

AJG-049 free base is a calcium channel antagonist that inhibits L-type Ca2+ channels via diltiazem-binding site(s).

Sas 1310 is a diltiazem derivative that acts as a calcium antagonist.